GSA Capital Partners’s Immunic IMUX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-177,381
| Closed | -$193K | – | 1931 |
|
|
2025
Q1 | $193K | Buy |
177,381
+61,439
| +53% | +$66.8K | 0.02% | 1402 |
|
|
2024
Q4 | $116K | Buy |
115,942
+83,176
| +254% | +$83.2K | 0.01% | 1501 |
|
|
2024
Q3 | $54K | Sell |
32,766
-83,999
| -72% | -$138K | ﹤0.01% | 1519 |
|
|
2024
Q2 | $130K | Buy |
+116,765
| New | +$130K | 0.01% | 1505 |
|
|
2023
Q1 | – | Sell |
-79,186
| Closed | -$111K | – | 1684 |
|
|
2022
Q4 | $111K | Buy |
79,186
+49,466
| +166% | +$69.3K | 0.01% | 1293 |
|
|
2022
Q3 | $94K | Buy |
+29,720
| New | +$94K | 0.01% | 1369 |
|
|
2019
Q2 | – | Sell |
-10,085
| Closed | -$80K | – | 1567 |
|
|
2019
Q1 | $80K | Buy |
10,085
+8,770
| +667% | +$69.6K | 0.01% | 1343 |
|
|
2018
Q4 | $10K | Buy |
+1,315
| New | +$10K | ﹤0.01% | 1290 |
|